Related references
Note: Only part of the references are listed.Mechanisms of checkpoint inhibition-induced adverse events
P. Urwyler et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2020)
Human Anti-tumor Immunity: Insights from Immunotherapy Clinical Trials
Jackson G. Egen et al.
IMMUNITY (2020)
B cells are associated with survival and immunotherapy response in sarcoma
Florent Petitprez et al.
NATURE (2020)
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
Rita Cabrita et al.
NATURE (2020)
B cells and tertiary lymphoid structures promote immunotherapy response
Beth A. Helmink et al.
NATURE (2020)
Regulatory T-cell Depletion Alters the Tumor Microenvironment and Accelerates Pancreatic Carcinogenesis
Yaqing Zhang et al.
CANCER DISCOVERY (2020)
Programmed Cell Death-1/ Ligand-1 PET Imaging A Novel Tool to Optimize Immunotherapy?
Sarah R. Verhoeff et al.
PET CLINICS (2020)
3D models in the new era of immune oncology: focus on T cells, CAF and ECM
Francesca Di Modugno et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology
Neel I. Nissen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment
Chin-King Looi et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Cancer stemness, intratumoral heterogeneity, and immune response across cancers
Alex Miranda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Targeting Tumor-Associated Macrophages in Cancer
Paulina Pathria et al.
TRENDS IN IMMUNOLOGY (2019)
Trial watch: dendritic cell vaccination for cancer immunotherapy
Jenny Sprooten et al.
ONCOIMMUNOLOGY (2019)
Immunometabolic Checkpoints of Treg Dynamics: Adaptation to Microenvironmental Opportunities and Challenges
Ilenia Pacella et al.
FRONTIERS IN IMMUNOLOGY (2019)
Neutrophil Heterogeneity in Cancer: From Biology to Therapies
Pacome Lecot et al.
FRONTIERS IN IMMUNOLOGY (2019)
18F-AzaFol for Detection of Folate Receptor-β Positive Macrophages in Experimental Interstitial Lung Disease-A Proof-of-Concept Study
Janine Schniering et al.
FRONTIERS IN IMMUNOLOGY (2019)
Oncolytic Viruses for Cancer Therapy: Barriers and Recent Advances
Meijun Zheng et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Tertiary lymphoid structures in the era of cancer immunotherapy
Catherine Sautes-Fridman et al.
NATURE REVIEWS CANCER (2019)
Zr-89-labeled nivolumab for imaging of T-cell infiltration in a humanized murine model of lung cancer
Christopher G. England et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Review of cancer treatment with immune checkpoint inhibitors
Christiane Thallinger et al.
WIENER KLINISCHE WOCHENSCHRIFT (2018)
Deconstruction of a Metastatic Tumor Microenvironment Reveals a Common Matrix Response in Human Cancers
Oliver M. T. Pearce et al.
CANCER DISCOVERY (2018)
Use of Immune Checkpoint Inhibitors in the Treatment of Patients With Cancer and Preexisting Autoimmune Disease A Systematic Review
Noha Abdel-Wahab et al.
ANNALS OF INTERNAL MEDICINE (2018)
Plasticity of myeloid-derived suppressor cells in cancer
Evgenii Tcyganov et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
NKp46 Receptor-Mediated Interferon-gamma Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis
Ariella Glasner et al.
IMMUNITY (2018)
Cancer immunotherapy beyond immune checkpoint inhibitors
Julian A. Marin-Acevedo et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
Combining chemotherapy with PD-1 blockade in NSCLC
Matthen Mathew et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Immuno-PET imaging of tumor-infiltrating lymphocytes using zirconium-89 radiolabeled anti-CD3 antibody in immune-competent mice bearing syngeneic tumors
Denis R. Beckford Vera et al.
PLOS ONE (2018)
Non-invasive visualization of tumor infiltrating lymphocytes in patients with metastatic melanoma undergoing immune checkpoint inhibitor therapy: a pilot study
Svetomir N. Markovic et al.
Oncotarget (2018)
The Role of indoleamine-2,3-Dioxygenase in Cancer Development, Diagnostics, and Therapy
Lilla Hornyak et al.
FRONTIERS IN IMMUNOLOGY (2018)
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang et al.
NATURE MEDICINE (2018)
Immunomodulation of Tumor Vessels: It Takes Two to Tango
Anna Johansson-Percival et al.
TRENDS IN IMMUNOLOGY (2018)
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
Spencer C. Wei et al.
CANCER DISCOVERY (2018)
Deciphering cancer fibroblasts
Giulia Biffi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy
Erhao Zhang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
INTRACAVITARY BACILLUS CALMETTE-GUERIN IN THE TREATMENT OF SUPERFICIAL BLADDER TUMORS
A. Morales et al.
JOURNAL OF UROLOGY (2017)
Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study
Matthew D. Hellmann et al.
LANCET ONCOLOGY (2017)
Elements of cancer immunity and the cancer-immune set point
Daniel S. Chen et al.
NATURE (2017)
The immune contexture in cancer prognosis and treatment
Wolf H. Fridman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
The integrative clinical impact of tumor-infiltrating T lymphocytes and NK cells in relation to B lymphocyte and plasma cell density in esophageal and gastric adenocarcinoma
Maria C. Svensson et al.
ONCOTARGET (2017)
Cancer immunotherapy: Historical Perspective of a Clinical Revolution and emerging Preclinical Animal Models
William K. Decker et al.
FRONTIERS IN IMMUNOLOGY (2017)
Natural Killer Cell Response to Chemotherapy-Stressed Cancer Cells: Role in Tumor Immunosurveillance
Alessandra Zingoni et al.
FRONTIERS IN IMMUNOLOGY (2017)
A novel immunohistochemical score to predict early mortality in acute myeloid leukemia patients based on indoleamine 2,3 dioxygenase expression
Abhishek Mangaonkar et al.
SCIENTIFIC REPORTS (2017)
Mesenchymal traits at the convergence of tumor-intrinsic and -extrinsic mechanisms of resistance to immune checkpoint blockers
Paola Trono et al.
EMERGING TOPICS IN LIFE SCIENCES (2017)
Deciphering the loop of epithelial-mesenchymal transition, inflammatory cytokines and cancer immunoediting
Antonella Sistigu et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2017)
Expansion of Tumor-Infiltrating CD8+ T cells Expressing PD-1 Improves the Efficacy of Adoptive T-cell Therapy
Sarita M. Fernandez-Poma et al.
CANCER RESEARCH (2017)
Metabolic Instruction of Immunity
Michael D. Buck et al.
CELL (2017)
Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies
Kristin G. Anderson et al.
CANCER CELL (2017)
An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy
Richard Tavare et al.
CANCER RESEARCH (2016)
Non-invasive tracking of CD4+ T cells with a paramagnetic and fluorescent nanoparticle in brain ischemia
Wei-Na Jin et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2016)
Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab
P. F. Ferrucci et al.
ANNALS OF ONCOLOGY (2016)
Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab
Alexander Martens et al.
CLINICAL CANCER RESEARCH (2016)
Clinical Significance of Circulating CD33+ CD11b+HLA-DR- Myeloid Cells in Patients with Stage IV Melanoma Treated with Ipilimumab
Moshe Sade-Feldman et al.
CLINICAL CANCER RESEARCH (2016)
Carcinoma-associated fibroblasts: orchestrating the composition of malignancy
Philippe Gascard et al.
GENES & DEVELOPMENT (2016)
Molecular Imaging of Immunotherapy Targets in Cancer
Emily B. Ehlerding et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
IL-6 Secreted from Cancer-Associated Fibroblasts Mediates Chemoresistance in NSCLC by Increasing Epithelial-Mesenchymal Transition Signaling
Yasushi Shintani et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps
Juwon Park et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Vincenzo Bronte et al.
NATURE COMMUNICATIONS (2016)
Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity
Sabina Sangaletti et al.
CELL REPORTS (2016)
Timing of CSF-1/CSF-1R signaling blockade is critical to improving responses to CTLA-4 based immunotherapy
Rikke B. Holmgaard et al.
ONCOIMMUNOLOGY (2016)
Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumors
MacLean Hall et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy
Hasan Rehman et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Expression of programmed death ligand-1 on tumor cells varies pre and post chemotherapy in non-small cell lung cancer
Jin Sheng et al.
SCIENTIFIC REPORTS (2016)
Regulatory circuits of T cell function in cancer
Daniel E. Speiser et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Hematological Effects, Serum, and Pulmonary Cytokine Profiles in a Melanoma Mouse Model Treated with GK1
Armando Perez-Torres et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2015)
Nutrient Competition: A New Axis of Tumor Immunosuppression
Madhusudhanan Sukumar et al.
CELL (2015)
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chih-Hao Chang et al.
CELL (2015)
CCR 20th Anniversary Commentary: Autologous T Cells-The Ultimate Personalized Drug for the Immunotherapy of Human Cancer
Steven A. Rosenberg
CLINICAL CANCER RESEARCH (2015)
Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab
Christoffer Gebhardt et al.
CLINICAL CANCER RESEARCH (2015)
Immunotherapy Approaches in Cancer Treatment
Pavel Klener et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2015)
In Vivo Imaging of Natural Killer Cell Trafficking in Tumors
Filippo Galli et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
PET Imaging of Tumor-Associated Macrophages with Zr-89-Labeled High-Density Lipoprotein Nanoparticles
Carlos Perez-Medina et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Immuno-PET of Murine T Cell Reconstitution Postadoptive Stem Cell Transplantation Using Anti-CD4 and Anti-CD8 Cys-Diabodies
Richard Tavare et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Distinct Functions of Neutrophil in Cancer and Its Regulation
Zvi Granot et al.
MEDIATORS OF INFLAMMATION (2015)
Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy
Shabnam Shalapour et al.
NATURE (2015)
4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors
Adrienne H. Long et al.
NATURE MEDICINE (2015)
The Predicted Impact of Ipilimumab Usage on Survival in Previously Treated Advanced or Metastatic Melanoma in the UK
James Larkin et al.
PLOS ONE (2015)
64Cu antibody-targeting of the T-cell receptor and subsequent internalization enables in vivo tracking of lymphocytes by PET
Christoph M. Griessinger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
T cell exclusion, immune privilege, and the tumor microenvironment
Johanna A. Joyce et al.
SCIENCE (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Harnessing nanopartricles for immune modulation
Daniel R. Getts et al.
TRENDS IN IMMUNOLOGY (2015)
Novel 89Zr cell labeling approach for PET-based cell trafficking studies
Aditya Bansal et al.
EJNMMI RESEARCH (2015)
Radiolabeling Strategies for Radionuclide Imaging of Stem Cells
Esther Wolfs et al.
STEM CELL REVIEWS AND REPORTS (2015)
Use of Human Hybridoma Technology To Isolate Human Monoclonal Antibodies
Scott A. Smith et al.
MICROBIOLOGY SPECTRUM (2015)
The extracellular matrix modulates the hallmarks of cancer
Michael W. Pickup et al.
EMBO REPORTS (2014)
Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
Peter J. Murray et al.
IMMUNITY (2014)
Cytokine Networks That Mediate Epithelial Cell-Macrophage Crosstalk in the Mammary Gland: Implications for Development and Cancer
Xuan Sun et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Imaging macrophages with nanoparticles
Ralph Weissleder et al.
NATURE MATERIALS (2014)
Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
Antonella Sistigu et al.
NATURE MEDICINE (2014)
Dendritic cell therapy in an allogeneic-hematopoietic cell transplantation setting: an effective strategy toward better disease control?
Maud Plantinga et al.
FRONTIERS IN IMMUNOLOGY (2014)
Hypoxia and the extracellular matrix: drivers of tumour metastasis
Daniele M. Gilkes et al.
NATURE REVIEWS CANCER (2014)
Clinical application of genetically modified T cells in cancer therapy
Michael H. Kershaw et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2014)
Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression
Inbal Mishalian et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Cancer immunotherapies, their safety and toxicity
Gheath Alatrash et al.
EXPERT OPINION ON DRUG SAFETY (2013)
Dendritic-Cell-Based Therapeutic Cancer Vaccines
Karolina Palucka et al.
IMMUNITY (2013)
Reciprocal Relationship between Myeloid-Derived Suppressor Cells and T Cells
Srinivas Nagaraj et al.
JOURNAL OF IMMUNOLOGY (2013)
Oncolytic viruses as therapeutic cancer vaccines
David L. Bartlett et al.
MOLECULAR CANCER (2013)
Targeting CXCL12 from FAP-expressing carcinomaassociated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
Christine Feig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Tracking immune cells in vivo using magnetic resonance imaging
Eric T. Ahrens et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Regulatory T Cells: Mechanisms of Differentiation and Function
Steven Z. Josefowicz et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
Labeling cells for in vivo tracking using 19F MRI
Mangala Srinivas et al.
BIOMATERIALS (2012)
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Douglas Hanahan et al.
CANCER CELL (2012)
Nanobody-Based Targeting of the Macrophage Mannose Receptor for Effective In Vivo Imaging of Tumor-Associated Macrophages
Kiavash Movahedi et al.
CANCER RESEARCH (2012)
CD20+ Tumor-Infiltrating Lymphocytes Have an Atypical CD27- Memory Phenotype and Together with CD8+ T Cells Promote Favorable Prognosis in Ovarian Cancer
Julie S. Nielsen et al.
CLINICAL CANCER RESEARCH (2012)
Fibroblast Activation Protein in Remodeling Tissues
M. Jacob et al.
CURRENT MOLECULAR MEDICINE (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
89Zr-Labeled Dextran Nanoparticles Allow in Vivo Macrophage Imaging
Edmund J. Keliher et al.
BIOCONJUGATE CHEMISTRY (2011)
Benefits of Hybrid SPECT/CT for 111In-Oxine- and Tc-99m-Hexamethylpropylene Amine Oxime-Labeled Leukocyte Imaging
Mehdi Djekidel et al.
CLINICAL NUCLEAR MEDICINE (2011)
Impact of Indium-111 Oxine Labelling on Viability of Human Mesenchymal Stem Cells In Vitro, and 3D Cell-Tracking Using SPECT/CT In Vivo
Franz Josef Gildehaus et al.
MOLECULAR IMAGING AND BIOLOGY (2011)
Differential Expression of the 18 kDa Translocator Protein (TSPO) by Neoplastic and Inflammatory Cells in Mouse Tumors of Breast Cancer
Jinzi Zheng et al.
MOLECULAR PHARMACEUTICS (2011)
Cell transfer immunotherapy for metastatic solid cancer-what clinicians need to know
Steven A. Rosenberg
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma
Douglas J. Schwartzentruber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer
Marc Cartellieri et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
B Cells Are Required for Optimal CD4+ and CD8+ T Cell Tumor Immunity: Therapeutic B Cell Depletion Enhances B16 Melanoma Growth in Mice
David J. DiLillo et al.
JOURNAL OF IMMUNOLOGY (2010)
B-cell-derived lymphotoxin promotes castration-resistant prostate cancer
Massimo Ammirante et al.
NATURE (2010)
Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein-α
Matthew Kraman et al.
SCIENCE (2010)
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: N1 versus N2 TAN
Zvi G. Fridlender et al.
CANCER CELL (2009)
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Kandice R. Levental et al.
CELL (2009)
Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1
Dong-Ming Kuang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
In vitro human leukocyte labeling with 64Cu: an intraindividual comparison with 111In-oxine and 18F-FDG
Kuldeep K. Bhargava et al.
NUCLEAR MEDICINE AND BIOLOGY (2009)
Optical Imaging of Cellular Immunotherapy against Prostate Cancer
Sidhartha Tavri et al.
MOLECULAR IMAGING (2009)
Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer
Khalid I. Al-Shibli et al.
CLINICAL CANCER RESEARCH (2008)
A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma. Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5 years
Bettina S. Nedergaard et al.
GYNECOLOGIC ONCOLOGY (2008)
CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer
Yoshiki Mizukami et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Self-delivering nanoemulsions for dual fluorine-19 MRI and fluorescence detection
Jelena M. Janjic et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
F. Stephen Hodi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Indium-111 oxine labelling affects the cellular integrity of haematopoietic progenitor cells
Bernd Nowak et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinoma
D. Ritchie et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Cancer despite immunosurveillance: immunoselection and immunosubversion
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Adeno-associated viral vector-mediated hypoxia-inducible vascular endothelial growth factor gene expression attenuates ischemic brain injury after focal cerebral ischemia in mice
Fanxia Shen et al.
STROKE (2006)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
In vivo cellular imaging of lymphocyte tracking by MRI:: A tumor model approach to cell-based anticancer therapy
Pierre Smirnov et al.
MAGNETIC RESONANCE IN MEDICINE (2006)
B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma
I Kryczek et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Allogeneic and autologous melanoma vaccines:: Where have we been and where are we going?
VK Sondak et al.
CLINICAL CANCER RESEARCH (2006)
De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent
KE de Visser et al.
CANCER CELL (2005)
Monitoring of a new approach of immunotherapy with allogenic 111In-labelled NK cells in patients with renal cell carcinoma
B Meller et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2004)
Cancer immunotherapy: The past, the present and the future
CR Parish
IMMUNOLOGY AND CELL BIOLOGY (2003)
The control of immunity and tolerance by dendritic cells
RM Steinman
PATHOLOGIE BIOLOGIE (2003)
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer
L Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Cancer immunotherapy:: The interferon-α experience
J Kirkwood
SEMINARS IN ONCOLOGY (2002)
Oncolytic biotherapy: a novel therapeutic platform
LK Hawkins et al.
LANCET ONCOLOGY (2002)
Biodistribution of 111indium-labeled macrophages infused intravenously in patients with renal carcinoma
V Quillien et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2001)
Tumor growth inhibition by intratumoral inoculation of defective herpes simplex virus vectors expressing granulocyte-macrophage colony-stimulating factor
M Toda et al.
MOLECULAR THERAPY (2000)
Share Paper
